Legend Biotech (LEGN) Total Liabilities: 2019-2025
Historic Total Liabilities for Legend Biotech (LEGN) over the last 5 years, with Sep 2025 value amounting to $701.7 million.
- Legend Biotech's Total Liabilities rose 13.23% to $701.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 8.61%. This contributed to the annual value of $629.6 million for FY2024, which is 5.42% up from last year.
- Per Legend Biotech's latest filing, its Total Liabilities stood at $701.7 million for Q3 2025, which was up 7.23% from $654.4 million recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Total Liabilities registered a high of $701.7 million during Q3 2025, and its lowest value of -$476.4 million during Q4 2021.
- In the last 3 years, Legend Biotech's Total Liabilities had a median value of $611.0 million in 2024 and averaged $602.8 million.
- Examining YoY changes over the last 5 years, Legend Biotech's Total Liabilities showed a top increase of 157,202.02% in 2021 and a maximum decrease of 483.16% in 2021.
- Over the past 5 years, Legend Biotech's Total Liabilities (Quarterly) stood at -$476.4 million in 2021, then skyrocketed by 223.15% to $586.7 million in 2022, then grew by 1.80% to $597.2 million in 2023, then rose by 5.42% to $629.6 million in 2024, then climbed by 13.23% to $701.7 million in 2025.
- Its Total Liabilities stands at $701.7 million for Q3 2025, versus $654.4 million for Q2 2025 and $597.9 million for Q1 2025.